These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 27699881)

  • 1. Structural basis of reversine selectivity in inhibiting Mps1 more potently than aurora B kinase.
    Hiruma Y; Koch A; Dharadhar S; Joosten RP; Perrakis A
    Proteins; 2016 Dec; 84(12):1761-1766. PubMed ID: 27699881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding inhibitor resistance in Mps1 kinase through novel biophysical assays and structures.
    Hiruma Y; Koch A; Hazraty N; Tsakou F; Medema RH; Joosten RP; Perrakis A
    J Biol Chem; 2017 Sep; 292(35):14496-14504. PubMed ID: 28726638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into Resistance Mechanisms of Inhibitors to Mps1 C604Y Mutation via a Comprehensive Molecular Modeling Study.
    Chen Y; Yu W; Jiang CC; Zheng JG
    Molecules; 2018 Jun; 23(6):. PubMed ID: 29925769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferential killing of p53-deficient cancer cells by reversine.
    Jemaà M; Galluzzi L; Kepp O; Boilève A; Lissa D; Senovilla L; Harper F; Pierron G; Berardinelli F; Antoccia A; Castedo M; Vitale I; Kroemer G
    Cell Cycle; 2012 Jun; 11(11):2149-58. PubMed ID: 22592527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A TPR domain-containing N-terminal module of MPS1 is required for its kinetochore localization by Aurora B.
    Nijenhuis W; von Castelmur E; Littler D; De Marco V; Tromer E; Vleugel M; van Osch MH; Snel B; Perrakis A; Kops GJ
    J Cell Biol; 2013 Apr; 201(2):217-31. PubMed ID: 23569217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversine, a novel Aurora kinases inhibitor, inhibits colony formation of human acute myeloid leukemia cells.
    D'Alise AM; Amabile G; Iovino M; Di Giorgio FP; Bartiromo M; Sessa F; Villa F; Musacchio A; Cortese R
    Mol Cancer Ther; 2008 May; 7(5):1140-9. PubMed ID: 18483302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissecting the role of MPS1 in chromosome biorientation and the spindle checkpoint through the small molecule inhibitor reversine.
    Santaguida S; Tighe A; D'Alise AM; Taylor SS; Musacchio A
    J Cell Biol; 2010 Jul; 190(1):73-87. PubMed ID: 20624901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the hot spot residues for pyridine derivative inhibitor CCT251455 and ATP substrate binding on monopolar spindle 1 (MPS1) kinase by molecular dynamic simulation.
    Chen K; Duan W; Han Q; Sun X; Li W; Hu S; Wan J; Wu J; Ge Y; Liu D
    J Biomol Struct Dyn; 2019 Feb; 37(3):611-622. PubMed ID: 29380674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TC Mps1 12, a novel Mps1 inhibitor, suppresses the growth of hepatocellular carcinoma cells via the accumulation of chromosomal instability.
    Choi M; Min YH; Pyo J; Lee CW; Jang CY; Kim JE
    Br J Pharmacol; 2017 Jun; 174(12):1810-1825. PubMed ID: 28299790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Mps1 kinase inhibitors: from purine to pyrrolopyrimidine and quinazoline leads.
    Bursavich MG; Dastrup D; Shenderovich M; Yager KM; Cimbora DM; Williams B; Kumar DV
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6829-33. PubMed ID: 24183538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-genome duplication increases tumor cell sensitivity to MPS1 inhibition.
    Jemaà M; Manic G; Lledo G; Lissa D; Reynes C; Morin N; Chibon F; Sistigu A; Castedo M; Vitale I; Kroemer G; Abrieu A
    Oncotarget; 2016 Jan; 7(1):885-901. PubMed ID: 26637805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of Interaction Mechanism between Pyrido [3,4-
    Xing C; Zhou X; Chen C; Sun W; Zheng Q; Liang D
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A crystal structure of the human protein kinase Mps1 reveals an ordered conformation of the activation loop.
    Roorda JC; Joosten RP; Perrakis A; Hiruma Y
    Proteins; 2019 Apr; 87(4):348-352. PubMed ID: 30582207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic localization of Mps1 kinase to kinetochores is essential for accurate spindle microtubule attachment.
    Dou Z; Liu X; Wang W; Zhu T; Wang X; Xu L; Abrieu A; Fu C; Hill DL; Yao X
    Proc Natl Acad Sci U S A; 2015 Aug; 112(33):E4546-55. PubMed ID: 26240331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biophysical and X-ray crystallographic analysis of Mps1 kinase inhibitor complexes.
    Chu ML; Lang Z; Chavas LM; Neres J; Fedorova OS; Tabernero L; Cherry M; Williams DH; Douglas KT; Eyers PA
    Biochemistry; 2010 Mar; 49(8):1689-701. PubMed ID: 20099905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular design and anticancer activities of small-molecule monopolar spindle 1 inhibitors: A Medicinal chemistry perspective.
    Wang S; Zhang M; Liang D; Sun W; Zhang C; Jiang M; Liu J; Li J; Li C; Yang X; Zhou X
    Eur J Med Chem; 2019 Aug; 175():247-268. PubMed ID: 31121430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis underlying resistance to Mps1/TTK inhibitors.
    Koch A; Maia A; Janssen A; Medema RH
    Oncogene; 2016 May; 35(19):2518-28. PubMed ID: 26364596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of 4-(4-aminopyrazolo[1,5-a][1,3,5]triazin-8-yl)benzamides as novel, highly potent and selective, orally bioavailable inhibitors of Tyrosine Threonine Kinase, TTK.
    Laufer R; Li SW; Liu Y; Ng G; Lang Y; Feher M; Brokx R; Beletskaya I; Hodgson R; Mao G; Plotnikova O; Awrey DE; Mason JM; Wei X; Lin DC; Che Y; Kiarash R; Madeira B; Fletcher GC; Mak TW; Bray MR; Pauls HW
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3562-6. PubMed ID: 27335255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A unique hinge binder of extremely selective aminopyridine-based Mps1 (TTK) kinase inhibitors with cellular activity.
    Kusakabe K; Ide N; Daigo Y; Itoh T; Yamamoto T; Kojima E; Mitsuoka Y; Tadano G; Tagashira S; Higashino K; Okano Y; Sato Y; Inoue M; Iguchi M; Kanazawa T; Ishioka Y; Dohi K; Kido Y; Sakamoto S; Ando S; Maeda M; Higaki M; Yoshizawa H; Murai H; Nakamura Y
    Bioorg Med Chem; 2015 May; 23(9):2247-60. PubMed ID: 25801152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characterization of CFI-402257, a potent and selective Mps1/TTK kinase inhibitor, for the treatment of cancer.
    Mason JM; Wei X; Fletcher GC; Kiarash R; Brokx R; Hodgson R; Beletskaya I; Bray MR; Mak TW
    Proc Natl Acad Sci U S A; 2017 Mar; 114(12):3127-3132. PubMed ID: 28270606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.